We are live on ! Find out more
BEAM icon

Beam Therapeutics
BEAM

224 hedge funds and large institutions have $2.6B invested in Beam Therapeutics in 2022 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 74 increasing their positions, 65 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

247% more call options, than puts

Call options by funds: $53.9M | Put options by funds: $15.5M

76% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 25

24% more capital invested

Capital invested by funds: $2.09B → $2.6B (+$509M)

14% more repeat investments, than reductions

Existing positions increased: 74 | Existing positions reduced: 65

9% more funds holding

Funds holding: 205 → 224 (+19)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0.26% less ownership

Funds ownership: 77.81% → 77.55% (-0.26%)

Holders
224
Holders Change
+19
Holders Change %
+9.27%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
44
Increased
74
Reduced
65
Closed
25
Calls
$53.9M
Puts
$15.5M
Net Calls
+$38.4M
Net Calls Change
+$44.4M

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$52.9M
2
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$21.4M
3
EAM
Eventide Asset Management
Massachusetts
+$15.2M
4
HRCM
Hood River Capital Management
Florida
+$13.1M
5
NAMA
Nikko Asset Management Americas
New York
+$12.5M

Top Sellers

1
Temasek Holdings
Temasek Holdings
Singapore
-$62.3M
2
State Street
State Street
Massachusetts
-$44.1M
3
AIM
ARK Investment Management
Florida
-$17.2M
4
DTC
Deep Track Capital
Connecticut
-$14.3M
5
Millennium Management
Millennium Management
New York
-$13.2M
Name Holding Trade Value Shares
Change 		Change in
Stake
VanEck Associates
176
VanEck Associates
New York
$34K +$40.8K +716 New
EWM
177
Endurance Wealth Management
Rhode Island
$30K – – –
AWM
178
AllSquare Wealth Management
New York
$27K – – –
CI Investments Inc
179
CI Investments Inc
Ontario, Canada
$25K -$2.17K -38 -7%
Macquarie Group
180
Macquarie Group
Australia
$24K -$29.1K -510 Closed
HNWAG
181
High Net Worth Advisory Group
Florida
$24K +$28.5K +500 New
HI
182
Hudock Inc
Pennsylvania
$23K – – –
APA
183
American Portfolios Advisors
New York
$21.4K +$25.7K +450 New
WFA
184
Wipfli Financial Advisors
Wisconsin
$21K +$25K +438 New
National Bank of Canada
185
National Bank of Canada
Quebec, Canada
$19K -$11.4K -200 -33%
AF
186
Allworth Financial
California
$19K -$3.99K -70 -15%
First Manhattan
187
First Manhattan
New York
$19K – – –
PI
188
PEAK6 Investments
Illinois
$18K +$22.1K +388 New
QT
189
Quantbot Technologies
New York
$14K -$627K -10,991 -97%
ADL
190
Asset Dedication LLC
California
$13K – – –
IA
191
IFP Advisors
Florida
$13K +$13.7K +240 +64%
Daiwa Securities Group
192
Daiwa Securities Group
Japan
$12K – – –
NFSG
193
Newbridge Financial Services Group
Florida
$12K – – –
TFM
194
TFC Financial Management
Massachusetts
$10K -$29.6K -518 -71%
BHWM
195
Beaird Harris Wealth Management
Texas
$10K – – –
LS
196
Leelyn Smith
Illinois
$10K – – –
TWA
197
TCI Wealth Advisors
Arizona
$9K -$856 -15 -7%
S
198
SignatureFD
Georgia
$6K – – –
RA
199
Rational Advisors
New York
$6K +$57 +1 +0.8%
DI
200
Disciplined Investments
Oklahoma
$5K – – –
6 7
8
9 10

BEAM Hedge Fund Activity: Q3 2022 in Review

224 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Beam Therapeutics (BEAM) for Q3 2022, worth a combined $2.6B — up 24% from $2.09B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new BEAM positions and 25 closed out — a net gain of 19 holders — while 74 added to existing stakes and 65 trimmed.

The largest buyer was Vanguard Group, adding an estimated $52.9M. The largest seller was Temasek Holdings, cutting an estimated $62.3M.

  • 224 institutional investors held Beam Therapeutics (BEAM) as of Q3 2022, up from 205 in Q2 2022.
  • Funds reported $2.6B of Beam Therapeutics stock for Q3 2022, up 24% quarter-over-quarter.
  • 44 funds opened new Beam Therapeutics positions in Q3 2022 and 25 closed out, a net change of +19 holders.
  • The largest Beam Therapeutics buyer in Q3 2022 was Vanguard Group, an estimated $52.9M added.
  • The largest Beam Therapeutics seller in Q3 2022 was Temasek Holdings, an estimated $62.3M sold.

Based on aggregated 13F filings for Q3 2022.